Anthony Lucci

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Table S2 from Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer

  2026-06-19

• Figure S1 from Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer

  2026-06-19

• Table S1 from Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer

  2026-06-19

• Data from Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer

  2026-06-19

• Examining the tumor microbiology and microenvironment of patients with triple-negative inflammatory breast cancer receiving KEYNOTE-522.

  Journal of Clinical Oncology · 2026-05-28

• Response to neoadjuvant chemotherapy in both the breast and lymph nodes in patients with inflammatory breast cancer.

  Journal of Clinical Oncology · 2026-05-27

• Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025

  Cancer · 2026-05-14

• The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer

  Breast Cancer Research · 2026-05-06

• Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection

  Annals of Surgical Oncology · 2026-04-24

• Abstract CT172: A phase II trial of adjuvant PD-1 blockade with endocrine therapy in hormone receptor positive inflammatory breast cancer: Circulating biomarkers and molecular correlates of clinical outcomes

  Cancer Research · 2026-04-17

• Abstract 3763: CCR7 expression and spatial distribution in inflammatory breast cancer: A baseline characterization for therapeutic targeting

  Cancer Research · 2026-04-03

• Abstract 7438: Residual disease on a dish: A practical approach to deep intrinsic resistance in melanoma

  Cancer Research · 2026-04-03

• Abstract 3744: Peripheral immune indices predict pathologic complete response and residual cancer burden in inflammatory breast cancers

  Cancer Research · 2026-04-03

• Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection

  Annals of Surgical Oncology · 2026-03-16

• A phenotype-based cell culture model of melanoma cells that persist as residual disease after therapies leading to recurrencePreprint

  Research Square · 2026-02-18

• Abstract PS2-01-25: Does surgery in a specialized clinic improve locoregional recurrence rates in Inflammatory Breast Cancer?

  Clinical Cancer Research · 2026-02-17

• Locoregional Nodal Status at Initial Presentation on Ultrasound (US) and Positron Emission Tomography/Computerized Tomography (18F-FDG PET/CT) in Inflammatory Breast Cancer (IBC) Patients is Predictive of Overall Survival

  Clinical Breast Cancer · 2026-02-13

• Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition

  Breast Cancer Research · 2025-12-10 · 1 citations

• Corrigendum to “International expert consensus on the clinical integration of circulating tumor cells in solid tumors” [Eur. J. Cancer 231 (2025) 116050]

  European Journal of Cancer · 2025-12-10

• Abstract A010: A cell culture model of quiescent melanoma cell state that governs cancer evolution, therapy resistance, and recurrence/metastasis

  Cancer Research · 2025-12-04